Soyez informé(e) par e-mail dès l'arrivée de cet article
Créer une alerte prix- Payez directement sur Rakuten (CB, PayPal, 4xCB...)
- Récupérez le produit directement chez le vendeur
- Rakuten vous rembourse en cas de problème
Gratuit et sans engagement
Félicitations !
Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !
TROUVER UN MAGASIN
Retour
Avis sur Lung Cancer Screening de Joanna Kusmirek Format Broché - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire
0 avis sur Lung Cancer Screening de Joanna Kusmirek Format Broché - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire
Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.
Présentation Lung Cancer Screening de Joanna Kusmirek Format Broché
- Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire
Résumé :
Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol. Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results. The evolution and future of lung cancer screenings Detection and management of unexpected incidental pulmonary and non-pulmonary findings Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.
Sommaire:
1 Lung Cancer Epidemiology 2 Risk Factors for Lung Cancer 3 Evolution of Lung Cancer Screening 4 Lung Cancer Screening Pros and Cons 5 Variable Imaging Presentations of Lung Cancer 6 Lung Cancer–Screening Results Reporting 7 Detection and Management of Unexpected Incidental Pulmonary and Nonpulmonary Findings 8 Elements of a Successful Lung Cancer–Screening Program 9 Future of Lung Cancer Screening 10 Test Cases: Applying Lung CT Screening Reporting and Data System (Lung-RADS)